de Almeida Danilo Candido, Bassi Ênio Jose, Azevedo Hatylas, Anderson Letícia, Origassa Clarice Silvia Taemi, Cenedeze Marcos Antônio, de Andrade-Oliveira Vinicius, Felizardo Raphael José Ferreira, da Silva Reinaldo Correia, Hiyane Meire Ioshie, Semedo Patricia, Dos Reis Marlene Antônia, Moreira-Filho Carlos Alberto, Verjovski-Almeida Sergio, Pacheco-Silva Álvaro, Câmara Niels Olsen Saraiva
Departamento de Medicina, Divisão de Nefrologia, Universidade Federal de São Paulo, São Paulo, Brazil; Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.
Departamento de Imunologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil; Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Alagoas, Maceió, Brazil.
Front Immunol. 2017 Jan 3;7:645. doi: 10.3389/fimmu.2016.00645. eCollection 2016.
Mesenchymal stromal cells (MSCs) orchestrate tissue repair by releasing cell-derived microvesicles (MVs), which, presumably by small RNA species, modulate global gene expression. The knowledge of miRNA/mRNA signatures linked to a reparative status may elucidate some of the molecular events associated with MSC protection. Here, we used a model of cisplatin-induced kidney injury (acute kidney injury) to assess how MSCs or MVs could restore tissue function. MSCs and MVs presented similar protective effects, which were evidenced and by modulating apoptosis, inflammation, oxidative stress, and a set of prosurvival molecules. In addition, we observed that miRNAs (i.e., miR-880, miR-141, miR-377, and miR-21) were modulated, thereby showing active participation on regenerative process. Subsequently, we identified that MSC regulates a particular miRNA subset which mRNA targets are associated with Wnt/TGF-β, fibrosis, and epithelial-mesenchymal transition signaling pathways. Our results suggest that MSCs release MVs that transcriptionally reprogram injured cells, thereby modulating a specific miRNA-mRNA network.
间充质基质细胞(MSC)通过释放细胞衍生的微泡(MV)来协调组织修复,这些微泡可能通过小RNA种类调节整体基因表达。与修复状态相关的miRNA/mRNA特征的知识可能阐明一些与MSC保护相关的分子事件。在这里,我们使用顺铂诱导的肾损伤(急性肾损伤)模型来评估MSC或MV如何恢复组织功能。MSC和MV呈现出相似的保护作用,这通过调节细胞凋亡、炎症、氧化应激和一组促生存分子得到了证实。此外,我们观察到miRNA(即miR-880、miR-141、miR-377和miR-21)受到调节,从而显示出它们在再生过程中的积极参与。随后,我们确定MSC调节一个特定的miRNA子集,其mRNA靶标与Wnt/TGF-β、纤维化和上皮-间质转化信号通路相关。我们的结果表明,MSC释放的MV可对受损细胞进行转录重编程,从而调节特定的miRNA-mRNA网络。